The number most prominently refers to BLA 125477 , the official Biologics License Application number for the FDA-approved drug Cyramza (ramucirumab) . Pharmaceutical Context (Cyramza)
Cyramza is a monoclonal antibody used to treat several types of advanced cancer by targeting the vascular endothelial growth factor receptor 2 (VEGFR2).
: Eli Lilly and Company (originally ImClone Systems LLC).
: On platforms like X (formerly Twitter), @125477 (helldermatador) is a user handle. 125477Orig1s000 - accessdata.fda.gov
: The original approval for gastric cancer occurred in April 2014 . Other References